The effect of a new beta blocking drug (butidrine) on some biohumoral indices, liver and kidney function and exercise tolerance.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D003327:Coronary Disease / Q000188:drug therapy*; D006801:Humans; D007668:Kidney / Q000187:drug effects*; D008099:Liver / Q000187:drug effects*; D008297:Male; D008875:Middle Aged; D005082:Physical Exertion; D013565:Sympatholytics / Q000627:therapeutic use*
D000319:Adrenergic beta-Antagonists; D013565:Sympatholytics